Lisinopril






628 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1282632 Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries. J Cardiovasc Pharmacol 1992 3
2 1312233 [Evaluation of the safety and efficacy of the lisinopril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in the treatment of essential arterial hypertension]. Minerva Med 1992 Jan-Feb 2
3 1314588 The functional role of tyrosine-200 in human testis angiotensin-converting enzyme. Biochem Biophys Res Commun 1992 Apr 15 1
4 1315560 Investigation of the biochemical effects of renin inhibition in normal volunteers treated by an ACE inhibitor. Br J Clin Pharmacol 1992 Mar 1
5 1317477 Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. Kidney Int 1992 Jan 2
6 1319250 Rapid reversal of angiotensin converting enzyme inhibition by lisinopril in the perfused rabbit lung. Pulm Pharmacol 1992 Jun 2
7 1320075 Effect of angiotensin converting enzyme inhibitors upon brain angiotensin II binding. J Hypertens 1992 Jun 1
8 1321187 Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J Hypertens 1992 Jul 1
9 1321247 Impact of angiotensin converting enzyme inhibition on the haemodynamic profile during laboratory stress tests. J Hum Hypertens 1992 Jun 3
10 1324678 Mixed-type inhibition of bovine lung angiotensin converting enzyme by lisinopril and its dansyl derivative. Biochem Pharmacol 1992 Aug 4 3
11 1325031 Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies. Mol Pharmacol 1992 Aug 4
12 1325885 Variation in angiotensin-converting enzyme (ACE) inhibitor affinity at two binding sites on rat pulmonary ACE: influence on bradykinin hydrolysis. Clin Exp Pharmacol Physiol 1992 May 3
13 1326422 Circulating angiotensin II levels under repeated administration of lisinopril in normal subjects. Clin Exp Pharmacol Physiol 1992 Aug 2
14 1327597 Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme. Clin Exp Pharmacol Physiol Suppl 1992 4
15 1329475 Angiotensin-converting enzyme inhibitors, left ventricular dysfunction, and early heart failure. Am J Cardiol 1992 Oct 8 2
16 1329481 Importance of long-acting angiotensin-converting enzyme inhibitors for congestive heart failure. Am J Cardiol 1992 Oct 8 1
17 1329541 Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells. Am J Physiol 1992 Oct 7
18 1330096 Fatal angioedema associated with lisinopril. Ann Pharmacother 1992 Oct 2
19 1333254 ACE-inhibition, kinins, and vascular PGI2 synthesis. Eicosanoids 1992 1
20 1335236 A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera. Biochem J 1992 Dec 15 2
21 1350796 Which anti-hypertensive to add to a beta-blocker: ACE inhibitor or diuretic? J Hum Hypertens 1992 Apr 2
22 1366257 Comparison between enalapril and lisinopril in mild-moderate hypertension: a comprehensive model for evaluation of drug efficacy. Blood Press 1992 Aug 2
23 1370299 Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-src expression. J Clin Invest 1992 Jan 2
24 1376274 Nitric oxide participation in renal hemodynamic effect of angiotensin converting enzyme inhibitor lisinopril. Eur J Pharmacol 1992 Mar 3 1
25 1376812 Antihypertensive effect of lisinopril assessed by 24-hour ambulatory monitoring: a double-blind, placebo-controlled, cross-over study. J Cardiovasc Pharmacol 1992 Jun 2
26 1575176 Hypertension in the elderly with a special focus on treatment with angiotensin-converting enzyme inhibitors and calcium antagonists. Am J Cardiol 1992 Apr 30 1
27 1629885 ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients. J Hum Hypertens 1992 Jun 1
28 1649623 Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry 1991 Jul 23 2
29 1653792 Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment. J Hypertens 1991 Jul 3
30 1658975 [Treatment of hypertension with the ACE inhibitor lisinopril. A multicenter study of patients with mild to moderate hypertension in general practice]. Tidsskr Nor Laegeforen 1991 Oct 30 1
31 1660550 Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition. Kidney Int 1991 Oct 2
32 1660796 Acute effects of the ACE inhibitor lisinopril on cardiac electrophysiological parameters of isolated guinea pig hearts. Clin Cardiol 1991 Jul 1
33 1662562 Different hemodynamic (24-h ambulatory blood pressure monitoring) and renin-inhibiting effect of a 1-week treatment with enalapril and lisinopril. Clin Cardiol 1991 Nov 3
34 1668266 Purification and characterization of recombinant human testis angiotensin-converting enzyme expressed in Chinese hamster ovary cells. Protein Expr Purif 1991 Feb 1
35 1706800 Pharmacokinetics and antihypertensive effects of lisinopril in hypertensive patients with normal and impaired renal function. J Cardiovasc Pharmacol 1990 Oct 3
36 1724523 Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril. J Cardiovasc Pharmacol 1991 Oct 5
37 1846675 Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules. Proc Soc Exp Biol Med 1991 Feb 3
38 1847721 Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J Intern Med 1991 Feb 4
39 1963909 A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans. Jpn J Pharmacol 1990 Oct 2
40 2155615 A deeply recessed active site in angiotensin-converting enzyme is indicated from the binding characteristics of biotin-spacer-inhibitor reagents. Biochem Biophys Res Commun 1990 Feb 28 2
41 2158900 Converting enzyme inhibition and vascular prostacyclin synthesis: effect of kinin receptor antagonism. Eur J Pharmacol 1990 Mar 13 1
42 2164644 Lisinopril: a new ACE inhibitor for the treatment of hypertension and congestive heart failure. Mt Sinai J Med 1990 May 1
43 2164777 Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 1990 Jul 5
44 2167741 Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats. Br J Pharmacol 1990 Jul 1
45 2172073 Fulminant hepatitis after lisinopril administration. Gastroenterology 1990 Dec 1
46 2173313 The antihypertensive effect and safety of lisinopril in patients with mild to moderate essential hypertension. A Belgian multicenter study. Acta Cardiol 1990 1
47 2175149 Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril. Am J Nephrol 1990 3
48 2189445 Angiotensin converting enzyme inhibitors. Am J Hypertens 1990 Apr 1
49 2207707 The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex. Brain Res Bull 1990 Jul 1
50 2285612 Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics. Cardiovasc Drugs Ther 1990 Feb 1